2024年GOLD慢性阻塞性肺疾病诊断、治疗、管理及预防全球策略更新要点解读  

Interpretation of Global Strategy for the Diagnosis,Treatment,Management and Prevention of Chronic Obstructive Pulmonary Disease 2024 Report

作　　者：陈典 隆寰宇 李姝润 陈亚红[1] CHEN Dian;LONG Huanyu;LI Shurun;CHEN Yahong(Department of Respiratory and Critical Care Medicine,Peking University Third Hospital,Beijing 100191,China)

机构地区：[1]北京大学第三医院呼吸与危重症医学科,北京市100191

出　　处：《中国全科医学》2024年第13期1533-1543,1567,共12页Chinese General Practice

基　　金：中央级公益性科研院所科研业务项目(2020-PT320-005)。

摘　　要：慢性阻塞性肺疾病全球倡议(GOLD)2024年修订版于2023-11-13发布,总体来说其对于慢性阻塞性肺疾病(以下简称慢阻肺)的定义、诊断、评估和治疗与2023年GOLD相同,但在10个方面进行了修订/扩充,包括扩充保留比值肺功能受损(PRISm)的概念、增加肺过度充气的部分、增加吸入支气管舒张剂前进行肺功能检查的说明、增加慢阻肺目标人群筛查的部分、更新血嗜酸性粒细胞计数的说明、更新间质性肺异常部分、修订戒烟部分、对慢阻肺患者的推荐疫苗进行更新、扩充吸入性治疗的管理部分以及新增戒烟的药物治疗。本文对更新内容进行简介和解读。Global initiative for chronic obstructive lung disease(GOLD)2024 report was released on November 13th,2023.In general,the definition,diagnosis,assessment,and therapy of chronic obstructive pulmonary disease(COPD)are the same as GOLD 2023,with corresponding content added in ten aspects,including the expansion of the information about PRISm,a new section on hyperinflation,further clarification about pre-bronchodilator spirometry,a new section on screening for COPD in targeted populations,the update of blood eosinophil count,the update of interstitial lung abnormalities,the revision of the section on smoking cessation,the update of vaccination recommendations for people with COPD,the expansion of managing inhaled therapy,and the addition of pharmacotherapies for smoking cessation.The article introduces and interprets the new contents.

关 键 词：肺疾病 慢性阻塞性 肺过度充气 肺功能 慢阻肺筛查 戒烟 指南 

分 类 号：R563.9[医药卫生—呼吸系统]